CBE Women conducts a variety of events year-round. Check this page to stay up-to-date!



CBE Women regularly hosts a variety of events: 

A lunch with a Cornell female faculty member for an informal conversation in a small group about career-path and building resilience.


Eat with Academic with Prof. Silvia Ferrari 

An opportunity for a conversation with the female seminar speakers over a Taverna Banfi breakfast right before the Monday morning seminar.

Breakfast with Prof. Lauren Bakaletz 

Usually an hour long workshop aimed at cultivating skills useful for graduate students in their future professional lives.

We invite an experienced professionals (often Cornell alumni) from academia/industry to talk about their journey

Prof. Alex Woltornist, Prof. Kathleen Vaeth, Dr. Jordan Atlas (Microsoft); 
Prof. Frank Lomax, Ken Rother (Enterpreneur), Dr.Andrea Ippolito

Building resilience within the community with some quality socializing

Apple Picking 2019!



The Lisa Walker Award allowed me to attend two virtual conferences, ACS Meetings & Expos and ACS Colloid and Surface Science Symposium in 2021. I was awarded in 2019, but because of the COVID19 pandemic, my conferences were postponed for one year. During this difficult time, thanks to the Lisa Walker Award, I was able to present my work on liquid crystal sensors for dynamic reaction pathways and active liquid crystal droplets that can both selfpropelling and
achieve functions, where I received a lot of interest from the audiences. I also attended the talks presented by top academic researchers and industrial leaders in chemistry, chemical engineering and biochemistry. These conferences were great professional development opportunities for me. The ideas inspired me not only on active materials and sensors that I am currently working on but also on directions I can possibly pursue my postdoc research.

CBE Women Xmas Party

This the season for merrymaking and celebrating, and what better way than with Christmas cookies and ugly sweaters?

CBE Women will be hosting a Christmas-themed social on Friday,
December 10 from 6 pm – 8 pm in Olin 128. There will be two main parts to the party: Christmas cookie decorating with the cookies and icing and sprinkles supplied, and Ugly Sweater designing with free sweatshirts and fabric paint and more supplied to the first-comers! Also, wear your favorite ugly sweater as there will be a vote and prize for the best one!

Come one, come all! Any GRADUATE student is invited because this event is funded by GPSAFC so bring your friends from other departments! See you all there!

CBEW Career Seminar: Job Opportunities in the Biopharmaceutical Industry

December 13th, 2-3 pm


1. Learn the processes involved in drug discovery and development.

2. Where in the research and development process might I work?

3. Learn the phases involved in FDA drug approval. How might those work environments differ?

4. Big company vs. small company approaches, and how those work environments differ


The speaker’s biography

Dave Pritchard has over 30 years’ experience as a senior manager in the biopharmaceutical industry working at the intersection of science, medicine, and business, with a focus on general management, business development and financial management. He has worked for public and private venture backed biotech companies (Series B-E), was a private and public company CFO, and led an IPO as a CEO. He served as KaloBios’ CEO for over 8 years from 2006 to early 2015. KaloBios was a first in class monoclonal antibody company with three drugs in phase 2 for asthma, serious infections, and cancer, and became a public company in 2013. Prior to KaloBios, he held the position of chief business officer at Rinat Neuroscience Corporation, where he managed the negotiations on the acquisition of the Rinat by Pfizer in 2006 for $500 million. Rinat developed antibodies that become Ajovy (fremanezumab) for migraine prevention, and tanezumab for arthritis pain. Prior to that he was chief financial officer at Matrix Pharmaceuticals and managed the sale of the company to Chiron Corporation in 2002 (now Novartis). He started his biotechnology career at Triton Biosciences, Inc. as one of the founding managers, and helped manage the sale of Triton (predominately to Schering AG, now Bayer). Triton developed Betaseron® for multiple sclerosis (2005-15 sales exceeded $1 billion/year), and Fludara® for chronic lymphocytic leukemia. David holds an MBA degree from Stanford University, and a BS in Chemical Engineering from Cornell. Mr. Pritchard has also served on the nonprofits biotechnology Boards of BayBio, ABFO in northern California, and the Biotech Business Development Roundtable of Northern California. He retired in 2015 and serves on nonprofit boards and travels internationally.

Reach Us

Our general meetings take place every month at Olin Hall, Cornell University

113 Ho Plaza

Ithaca NY 14853

Leave A Message